S&S (4198.TWO) monthly revenue, September 2026
S&S reported revenue of NT$0.02bn for September 2026, up 45.7% from the previous month and up 13.5% from a year earlier. Year-to-date revenue was NT$0.13bn, down 13.7% year on year. It ranked 68 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.02 | 45.7 | 13.5 |